[ad_1] For all the attention paid to the highflying tech giants dubbed the Magnificent Seven,…
CH:ROG
-
-
STOCK MARKET
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
by userby user[ad_1] Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion,…
-
STOCK MARKET
Nvidia stock rises ahead of results, Foot Locker and Peloton tank, and other stocks on the move
by userby user[ad_1] Here are some of the biggest movers of the day: Stock gainers: Nvidia shares…
-
STOCK MARKET
Roche’s Tecentriq shows further good survival rates as cancer treatment
by userby user[ad_1] Roche Holding AG said Sunday that its tecentriq immunotherapy drug showed further positive results…
-
[ad_1] A U.S. Food and Drug Administration committee voted in favor of Roche Holding AG’s…
-
STOCK MARKET
This chart offers one reason that European stocks may continue to outperform U.S. equities
by userby user[ad_1] One of the stories for markets this year has been the outperformance of European…
-
STOCK MARKET
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
by userby user[ad_1] Back around 2005, in a pharmaceutical research lab in Nutley, N.J., Becky Taub noticed…
-
[ad_1] Eisai 4523, +1.23% plans to share additional data about the Alzheimer’s disease treatment it’s…
-
[ad_1] Roche Holding AG said Wednesday that its monkeypox virus test has received emergency use…
-
[ad_1] Roche Holding AG said Monday that its vision-loss treatment Vabysmo has been approved in…
- 1
- 2